Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tiaozhi Qinggan
- Development stage
- Unknown
- Lead developer
- Jilin Beiyao Medicine Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Tiaozhi Qinggan is a Traditional Chinese Medicine (TCM) formulation developed by Jilin Province Beiyao Pharmaceutical Material Station for the treatment of non-alcoholic fatty liver disease (NAFLD) and hyperlipidemia. The preparation, typically found in granule form, is composed of several herbal ingredients including *Crataegus pinnatifida*, *Alisma plantago-aquatica*, and *Salvia miltiorrhiza*. It functions by regulating lipid metabolism, reducing hepatic fat accumulation, and providing antioxidant effects to protect hepatocytes. Clinical use in China focuses on patients with phlegm-dampness and blood stasis patterns according to TCM diagnostics, effectively lowering serum cholesterol and triglyceride levels while improving liver function markers.
- Brand names
- Tiaozhi Qinggan Granules
- Other names
- Tiaozhi Qinggan KeliTiaozhi Qinggan CapsuleTiaozhi Qinggan Tang
02
Targets
HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)PPARA (Peroxisome proliferator-activated receptor alpha)
Beyond the preview
Go deeper on Tiaozhi Qinggan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tiaozhi Qinggan.